Australia markets closed

Concord Medical Services Holdings Limited (CCM)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.6600-0.0400 (-5.71%)
As of 11:59AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 30.39M
Enterprise value 477.45M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)3.00
Enterprise value/revenue 0.89
Enterprise value/EBITDA -1.83

Trading information

Stock price history

Beta (5Y monthly) -0.17
52-week change 3-49.64%
S&P500 52-week change 322.43%
52-week high 31.6000
52-week low 30.3800
50-day moving average 30.5438
200-day moving average 30.9912

Share statistics

Avg vol (3-month) 313.35k
Avg vol (10-day) 321.59k
Shares outstanding 543.42M
Implied shares outstanding 643.42M
Float 842.02M
% held by insiders 118.00%
% held by institutions 10.19%
Shares short (15 Apr 2024) 46.93k
Short ratio (15 Apr 2024) 40.37
Short % of float (15 Apr 2024) 40.03%
Short % of shares outstanding (15 Apr 2024) 40.02%
Shares short (prior month 15 Mar 2024) 46.97k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 329 Jan 2016
Ex-dividend date 423 Dec 2015
Last split factor 211384:10000
Last split date 316 Jan 2014

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -55.39%
Operating margin (ttm)-98.45%

Management effectiveness

Return on assets (ttm)-4.80%
Return on equity (ttm)-28.23%

Income statement

Revenue (ttm)537.4M
Revenue per share (ttm)12.30
Quarterly revenue growth (yoy)-22.90%
Gross profit (ttm)N/A
EBITDA -344.16M
Net income avi to common (ttm)-297.66M
Diluted EPS (ttm)-0.9400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)58.14M
Total cash per share (mrq)0.45
Total debt (mrq)3.3B
Total debt/equity (mrq)188.65%
Current ratio (mrq)0.32
Book value per share (mrq)-48.87

Cash flow statement

Operating cash flow (ttm)-276.47M
Levered free cash flow (ttm)-51.94M